Latest period
$1.83B
YoY change
+2.8%
5Y CAGR
+1.0%
Peak year (2022)
$2.14B
Latest annual
$1.75B
Total Liabilities history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: $1.75B
Total Liabilities growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: +2.8%
Total Liabilities history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| 2025 | $1.75B | +2.8% | +$47.25M | ||
| 2024 | $1.70B | -4.4% | −$77.27M | ||
| 2023 | $1.78B | -17.0% | −$362.63M | ||
| 2022 | $2.14B | +22.4% | +$390.82M | ||
| 2021 | $1.75B | +5.1% | +$85.44M | ||
| 2020 | $1.66B | +0.4% | +$7.12M | ||
| 2019 | $1.65B | +7.0% | +$108.07M | ||
| 2018 | $1.55B | -12.5% | −$220.68M | ||
| 2017 | $1.77B | +7.8% | +$128.34M | ||
| 2016 | $1.64B | +5.1% | +$79.93M | ||
| 2015 | $1.56B | +23.1% | +$292.37M | ||
| 2014 | $1.27B | +77.8% | +$554.32M | ||
| 2013 | $712.30M | +52.4% | +$244.96M | ||
| 2012 | $467.35M | -4.9% | −$23.88M | ||
| 2011 | $491.22M | +52.1% | +$168.36M | ||
| 2010 | $322.86M | +9.8% | +$28.91M | ||
| 2009 | $293.95M | -10.2% | −$33.30M | ||
| 2008 | $327.24M | +24.0% | +$63.39M | ||
| 2007 | $263.86M | +76.3% | +$114.16M | ||
| 2006 | $149.70M | +23.3% | +$28.33M | ||
| 2005 | $121.37M | +4.1% | +$4.79M | ||
| 2004 | $116.58M | +7.4% | +$7.99M | ||
| 2003 | $108.58M | +43.5% | +$32.90M | ||
| 2002 | $75.68M | +6.0% | +$4.30M | ||
| 2001 | $71.38M | -3.6% | −$2.67M | ||
| 2000 | $74.05M | -2.4% | −$1.85M | ||
| 1999 | $75.90M | -8.2% | −$6.80M | ||
| 1998 | $82.70M | +11.3% | +$8.40M | ||
| 1997 | $74.30M | +45.1% | +$23.10M | ||
| 1996 | $51.20M | +53.3% | +$17.80M | ||
| 1995 | $33.40M | +52.5% | +$11.50M | ||
| 1994 | $21.90M | +52.1% | +$7.50M | ||
| 1993 | $14.40M | +54.8% | +$5.10M | ||
| 1992 | $9.30M | +40.9% | +$2.70M | ||
| 1991 | $6.60M | — | — |
- 2025$1.75B+2.8%
- 2024$1.70B-4.4%
- 2023$1.78B-17.0%
- 2022$2.14B+22.4%
- 2021$1.75B+5.1%
- 2020$1.66B+0.4%
- 2019$1.65B+7.0%
- 2018$1.55B-12.5%
- 2017$1.77B+7.8%
- 2016$1.64B+5.1%
- 2015$1.56B+23.1%
- 2014$1.27B+77.8%
- 2013$712.30M+52.4%
- 2012$467.35M-4.9%
- 2011$491.22M+52.1%
- 2010$322.86M+9.8%
- 2009$293.95M-10.2%
- 2008$327.24M+24.0%
- 2007$263.86M+76.3%
- 2006$149.70M+23.3%
- 2005$121.37M+4.1%
- 2004$116.58M+7.4%
- 2003$108.58M+43.5%
- 2002$75.68M+6.0%
- 2001$71.38M-3.6%
- 2000$74.05M-2.4%
- 1999$75.90M-8.2%
- 1998$82.70M+11.3%
- 1997$74.30M+45.1%
- 1996$51.20M+53.3%
- 1995$33.40M+52.5%
- 1994$21.90M+52.1%
- 1993$14.40M+54.8%
- 1992$9.30M+40.9%
- 1991$6.60M—
Total Liabilities values are taken from IDEXX Laboratories's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's latest reported total liabilities is $1.83B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total liabilities for IDEXX Laboratories (IDXX) came in at $1.75B – edged up 2.8% year-over-year.
Across 2020–2025 (5 years), IDEXX Laboratories total liabilities produced a CAGR of +1.0% – with mixed annual results across the window.
$2.14B stands as the all-time-high annual total liabilities, posted in 2022, against a low of $6.60M during 1991.
IDEXX Laboratories Total Liabilities by Year
IDEXX Laboratories Total Liabilities 2025: $1.75B
IDEXX Laboratories total liabilities in 2025 was $1.75B, edged up 2.8% from 2024.
IDEXX Laboratories Total Liabilities 2024: $1.70B
2024's total liabilities for IDEXX Laboratories came in at $1.70B, edged down 4.4% below 2023.
IDEXX Laboratories Total Liabilities 2023: $1.78B
IDEXX Laboratories posted total liabilities of $1.78B in 2023, declined 17.0% below 2022.
IDEXX Laboratories Total Liabilities 2022: $2.14B
In 2022, IDEXX Laboratories reported total liabilities of $2.14B, grew 22.4% from 2021. This figure represents the highest annual value in the available history.
IDEXX Laboratories Total Liabilities 2021: $1.75B
IDEXX Laboratories total liabilities in 2021 was $1.75B.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers by Total Liabilities
Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation